Target antigen density governs the efficacy of anti–CD20-CD28-CD3 ζ chimeric antigen receptor–modified effector CD8+ T cells

…, T Goto, R Hanajiri, N Imahashi… - The Journal of …, 2015 - journals.aai.org
The effectiveness of chimeric Ag receptor (CAR)–transduced T (CAR-T) cells has been
attributed to supraphysiological signaling through CARs. Second-and later-generation CARs …

Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells

…, PP Banerjee, M Shanley, N Imahashi… - Blood, The Journal …, 2021 - ashpublications.org
Immune checkpoint therapy has resulted in remarkable improvements in the outcome for
certain cancers. To broaden the clinical impact of checkpoint targeting, we devised a strategy …

[HTML][HTML] Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells

…, E Liu, J Yu, N Imahashi… - The Journal of …, 2021 - Am Soc Clin Investig
Glioblastoma multiforme (GBM), the most aggressive brain cancer, recurs because glioblastoma
stem cells (GSCs) are resistant to all standard therapies. We showed that GSCs, but not …

Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD …

…, M Daher, R Basar, M Muftuoglu, N Imahashi… - Leukemia, 2018 - nature.com
Ibrutinib, a covalent inhibitor of Bruton Tyrosine Kinase (BTK), is approved for treatment of
patients with relapsed/refractory or treatment-naïve chronic lymphocytic leukemia (CLL). …

[HTML][HTML] SARS-CoV-2 accessory protein ORF8 is secreted extracellularly as a glycoprotein homodimer

K Matsuoka, N Imahashi, M Ohno, H Ode… - Journal of Biological …, 2022 - ASBMB
ORF8 is an accessory protein encoded by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2). Consensus regarding the biological functions of ORF8 is lacking, largely …

Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation

…, D Armstrong-James, N Imahashi… - Blood, The Journal …, 2016 - ashpublications.org
The ability of cord blood transplantation (CBT) to prevent relapse depends partly on donor
natural killer (NK) cell alloreactivity. NK effector function depends on specific killer-cell …

Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease

…, M Yanagisawa, N Imahashi… - Blood, The Journal …, 2009 - ashpublications.org
We retrospectively reviewed 104 biopsy specimens of previously untreated skin acute graft-versus-host
disease (GVHD) within 100 days after allogeneic stem cell transplantation, and …

A robust, good manufacturing practice–compliant, clinical-scale procedure to generate regulatory T cells from patients with amyotrophic lateral sclerosis for adoptive …

…, I Kaur, J Zulovich, E Yvon, M Muftuoglu, N Imahashi… - Cytotherapy, 2016 - Elsevier
Regulatory T cells (Tregs) play a fundamental role in the maintenance of self-tolerance and
immune homeostasis. Defects in Treg function and/or frequencies have been reported in …

A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation

…, H Shaim, M Daher, R Basar, N Imahashi… - Blood …, 2019 - ashpublications.org
Natural killer (NK) cells are highly heterogeneous, with vast phenotypic and functional
diversity at the single-cell level. They are involved in the innate immune response against …

[HTML][HTML] Dexamethasone palmitate ameliorates macrophages-rich graft-versus-host disease by inhibiting macrophage functions

…, S Terakura, S Saito, T Kato, H Mizuno, N Imahashi… - PloS one, 2014 - journals.plos.org
Macrophage infiltration of skin GVHD lesions correlates directly with disease severity, but
the mechanisms underlying this relationship remain unclear and GVHD with many …